Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron for CINV in Aggressive NHL
NCT01018758Phase 2Completed
- Sponsor
- Gruppo Italiano Studio Linfomi
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Gruppo Italiano Studio Linfomi. Started Jul 2006; status: completed.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01018758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018758.